Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immunesuppressive agents

Details for Australian Patent Application No. 2001268718 (hide)

Owner Abbott Laboratories

Inventors Gentles, Robert; Wang, Gary T; Wang, Sheldon

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001268718

PCT Pub. Number WO02/02539

Priority 09606717 29.06.00 US

Filing date 22 June 2001

Wipo publication date 14 January 2002

Acceptance publication date 5 January 2006

International Classifications

C07D 263/48 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A61K 31/425 (2006.01) - Thiazoles

A61K 31/505 (2006.01) - Pyrimidines

C07D 233/00 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 239/00 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 277/42 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

5 January 2006 Application Accepted

  Published as AU-B-2001268718

4 May 2006 Standard Patent Sealed

15 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001268719-Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates

2001268717-METHOD AND SYSTEM FOR CALL ADMINISTRATION